Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media Xinhua provided details regarding Tuesday.
The antibodies are being created by a Beijing-based unit of Nasdaq-recorded Sinovac Biotech, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed China National Pharmaceutical Group.
In March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China’s Academy of Military Medical Sciences and HK-recorded biotech firm CanSino Bio, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the U.S. National Institutes of Health.
